This brand name is authorized in Brazil
The drug MEVATYL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Cannabidiol
UNII 19GBJ60SN5 - CANNABIDIOL
|
|
Cannabidiol is indicated for the treatment of seizures associated with Lennox‑Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older. |
|
2
Tetrahydrocannabinol
UNII 7J8897W37S - DRONABINOL
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 539217070000902 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
